15 minute intraday candlestick chart, ~15 minute delayCurrently unavailable for this symbol.
Try again later today or try daily, weekly, monthly or quarterly charts.
15 minute intraday candlestick chart, ~15 minute delayCurrently unavailable for this symbol.
Try again later today or try daily, weekly, monthly or quarterly charts.
CSTL News
12-Jan-2025 5:00 PM CST - Business Wire Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced certain unaudited preliminary performance results for the fourth quarter and year ended Dec. 31, 2024. Our strong fourth quarter performance underscores continued momentum built throughout 2024, reflecting the strength of our growth initiatives and the dedication of our team, said Derek Maetzold, president and chief executiv
4-Nov-2024 3:05 PM CST - Business Wire Castle Biosciences Reports Third Quarter 2024 Results $CSTL #CSTL--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the third quarter and nine months ended September 30, 2024. We are thrilled with our third quarter performance, which reflects the continued success of our growth initiatives and the dedication of our team, said Derek Maetzold, president and chief executive officer of Castle Biosciences. We believe
12-Jan-2025 5:00 PM CST - Business Wire Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced certain unaudited preliminary performance results for the fourth quarter and year ended Dec. 31, 2024. Our strong fourth quarter performance underscores continued momentum built throughout 2024, reflecting the strength of our growth initiatives and the dedication of our team, said Derek Maetzold, president and chief executiv
4-Nov-2024 3:05 PM CST - Business Wire Castle Biosciences Reports Third Quarter 2024 Results $CSTL #CSTL--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the third quarter and nine months ended September 30, 2024. We are thrilled with our third quarter performance, which reflects the continued success of our growth initiatives and the dedication of our team, said Derek Maetzold, president and chief executive officer of Castle Biosciences. We believe